Ashley J. Stevens, D. Phil (Oxon), CLP
Special Assistant to the VP of Research
Office of Technology Development, Boston University
Senior Research Associate
Institute for Technology Entrepreneurship and Commercialization, School of Management, Boston University
Association of University Technology Managers
In 2010, Dr. Stevens became Special Assistant to the VP of Research at Boston University, where he has been tasked with exploring the faculty’s interest in launching a university-wide academic program focused on the role of intellectual property and the evolution of models for the translation of ideas and knowledge into economic development. Previously, he spent 15 years as Director and then Executive Director, Technology Transfer in the Office of Technology Development at Boston University.
He is also Senior Research Associate in the Institute for Technology Entrepreneurship and Commercialization in Boston University’s School of Management, where he teaches two graduate-level, inter-disciplinary courses on Technology Commercialization. Before joining Boston University, he was Director of the Office of Technology Transfer at the Dana-Farber Cancer Institute, a teaching affiliate of the Harvard Medical School.
Since he joined Boston University, the Office of Technology Development has spun out over 50 companies based on the University’s research, a number of which have raised substantial amounts of capital, and the University’s licensing income climbed steadily.
Prior to entering the technology transfer profession, Dr. Stevens worked in the biotechnology industry for nearly ten years. He was a co-founder of Kytogenics, Inc., of which he is still a Director, was co-founder and General Manager of Genmap, Inc., and was Vice President of Business Development for BioTechnica International. He started his career with The Procter & Gamble Company, where he held a number of positions in sales, marketing, strategic planning and acquisitions.
Dr. Stevens publishes and lectures frequently on many aspects of technology transfer, including the Bayh-Dole Act, the economic impact of technology transfer and its role in economic development, the contribution of academia to the discovery of new drugs and vaccines, the role of technology transfer in global health and technology valuation. He was the recipient of the Bayh-Dole Award at Association of University Technology Managers 2007 Annual Meeting and became President of AUTM in March 2010. He is also active in the Licensing Executives Society and the Massachusetts Biotechnology Council.
Dr. Stevens holds a Bachelor of Arts in Natural Sciences, a Master of Arts and a Doctor of Philosophy in Physical Chemistry from Oxford University. He is a Certified Licensing Professional.